Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia

NCT03004469 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

458

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia, Androgenetic

Interventions

DRUG: P-3074
DRUG: Finasteride
DRUG: P-3074 Vehicle
DRUG: Finasteride Placebo

Sponsor

Polichem S.A.